Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function

Completed

Phase 2 Results

Summary of Purpose

The purpose of this study is to evaluate the safety of injections of botulinum toxin Type A in patients with reduced lung function and focal upper limb poststroke spasticity

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 August 2011.

1 Oct 2003 29 Jan 2004 1 Aug 2009 1 Aug 2009 1 Aug 2011 28 Jul 2011
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts

  • Allergan Inc.

    clinicaltrials@allergan.com